Loading
Latest filing published 28 Nov 2023 for SAB Biotherapeutics, Inc..
No signal scores available.
Helen K. Ellias has a single filing on record, published on 28 November 2023: an option exercise in SAB Biotherapeutics, Inc. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration